Sign in
4

Changes in Ownership

Raphael Pharmaceutical Inc. Filed Acc 0001213900-24-025519

Chief Technology Officer acquired 999,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Louria Hayon Igal Chief Technology Officer 2023-08-29 Option exercise +999,000 $0.01 $9,990 999,000 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Louria Hayon Igal Chief Technology Officer 2023-08-29 Option exercise · Warrants to purchase Common Stock −999,000 0 D: show line 2 in the form
Loading xslF345X05/ownership.xml…